Quest Diagnostics (DGX) Other Non-Current Liabilities (2016 - 2026)
Quest Diagnostics' Other Non-Current Liabilities history spans 18 years, with the latest figure at $1.0 billion for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 11.45% to $1.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.0 billion, a 11.45% increase, with the full-year FY2025 number at $957.0 million, up 2.03% from a year prior.
- Other Non-Current Liabilities hit $1.0 billion in Q1 2026 for Quest Diagnostics, up from $957.0 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for DGX hit a ceiling of $1.0 billion in Q1 2026 and a floor of $6.0 million in Q2 2024.
- Historically, Other Non-Current Liabilities has averaged $772.7 million across 5 years, with a median of $874.0 million in 2023.
- Biggest five-year swings in Other Non-Current Liabilities: tumbled 93.18% in 2024 and later surged 14733.33% in 2025.
- Tracing DGX's Other Non-Current Liabilities over 5 years: stood at $812.0 million in 2022, then grew by 7.88% to $876.0 million in 2023, then rose by 7.08% to $938.0 million in 2024, then increased by 2.03% to $957.0 million in 2025, then rose by 6.79% to $1.0 billion in 2026.
- Business Quant data shows Other Non-Current Liabilities for DGX at $1.0 billion in Q1 2026, $957.0 million in Q4 2025, and $982.0 million in Q3 2025.